Hospice News on April 9 surveyed three vendors selling interactive AI representations of the deceased to grieving families: HereAfter AI, Eternos.life and You, Only Virtual. [1] All three are signing contracts with hospice and palliative-care programs in 2026. The American Academy of Hospice and Palliative Medicine has not yet issued formal guidance. The American Hospice Foundation has guidance pending. The contracts are arriving before the protocol is. The bereaved families this paper covers are being asked to consent to a thing the field of bereavement clinical care does not yet have a name for.

What the three vendors sell is technically distinct. HereAfter AI, the most publicly accessible product, runs a friendly virtual interviewer that prompts the user to record audio stories about their life — childhood, relationships, personality, photographs and the stories behind them — at three subscription tiers ($3.99/month Starter, $5.99/month Storyteller, $7.99/month Unlimited). [2] After death, family members ask the app questions; it answers in the deceased's recorded voice, retrieving stored audio that matches the question. The interaction is search-grade rather than generative; the voice is real, the words were actually spoken, and the system retrieves rather than synthesizes.

Eternos.life is the most generative. The launch client, German entrepreneur Michael Bommer, who has terminal cancer, recorded 300 phrases over a two-day computing process; Eternos compressed the data to capture his voice; the system answers arbitrary questions in his voice with synthetically generated language, drawing on recorded personality and personal history rather than retrieving pre-recorded files. [3] The setup cost was approximately $15,000 for Bommer's case; legal rights to the AI persona belong to the trained subject and pass down as an estate asset. CEO Robert LoCascio told CBS News and AP the company "doesn't want to get into the grief tech or even post-death legacy space" but acknowledged the market position the Bommer case occupies. [4]

You, Only Virtual occupies the middle ground: video- and voice-trained avatars built from longer biographical material, sold through hospice partnerships rather than direct-to-consumer, with grief-clinical framing in the marketing copy. The Hospice News survey identified the company as one of the three vendors most actively contracting with palliative-care programs in 2026. [1] The pricing structure is contract-driven and varies by hospice; the average reported in coverage was lower than Eternos's $15,000 setup but higher than HereAfter's monthly subscription tier. None of the three vendors publicly disclose lifetime data ownership terms in customer-facing materials; all three operate under broader EULAs that consumers sign at signup.

The clinical objection is documented but unresolved. Hospice News quoted bereavement clinicians on April 9 warning that "consistent, artificially-generated interaction" with a representation of a dead loved one creates "new complexities" that bereavement care has no protocol for. [1] The concern is not that the bots themselves are clinically harmful in any single interaction — the concern is that prolonged or daily interaction may interfere with the grief process the field has, for forty years, organized around the conceptual model of "moving through" loss rather than maintaining real-time interactivity with it. The Pauline Boss "ambiguous loss" framework, which has guided hospice grief programs since the 1990s, was not designed for clients who can chat with a recorded simulation of their dead spouse on their phone before bed.

The consumer products, meanwhile, are shipping. ChatGPT custom GPTs explicitly marketed for grief and elderly companionship are available through OpenAI's GPT Store at consumer pricing. None of those custom GPTs are FDA-regulated; none are bound by HIPAA; their training data and conversation logs are subject to the consumer-tier privacy policies of the underlying foundation model providers. The hospice-program-contracted products are different in kind: they are negotiated under business-associate agreements when integrated with electronic health records, and they sit inside a regulatory environment palliative-care administrators understand. The consumer products and the hospice products are converging on the same family.

For the bereaved family, three operational questions matter. Data ownership: HereAfter ties data to the active account; Eternos transfers ownership to the AI's legal subject and successors; You, Only Virtual's terms vary by hospice. The 2026 Hospice News survey found inconsistent answers across vendor websites. Access: HereAfter limits access to authorized family; Eternos gives the legal-rights holder full discretion; You, Only Virtual routes access through hospice intake. Clinical oversight: none of the three vendors currently require social-work consultation before activation. The intake form is the consent form. The consent form is, in 2026, often signed on day three of bereavement.

For the hospice administrator, the procurement question is sharper. The American Academy of Hospice and Palliative Medicine has not issued a position statement. Without one, hospice programs evaluate the products against general HIPAA and BAA standards rather than bereavement-specific protocols. The Medicare Hospice Benefit covers bereavement services for thirteen months after a patient's death but does not include AI grief-bot services as a covered modality. Some private hospice riders reimburse case-by-case. None of the three vendors named here is yet a standard benefit.

The cultural question is what the thing itself is. Eternos's marketing uses "digital twin." HereAfter's uses "Life Story Avatar." You, Only Virtual's emphasizes "presence." The bereavement-clinical literature does not yet have terminology that maps to any of these. The "deathbot" label, which trade press has been pushing since 2024, has the virtue of clarity and the disadvantage of valence that makes hospice administrators uncomfortable. [3] The patients call them what they are: ways to keep talking to the dead. [4]

For the paper, this is service journalism with a Didion frame. The texture of American dying is being reorganized around a software product line that arrived before its protocol. Three vendors are signing contracts. Hospice social workers are improvising consent forms. Families are choosing under conditions of grief rather than evaluation. The product is going to be on the bedside table in some American living room tonight, on a tablet next to a tissue box and a photograph. The thing in the photograph is the same in every household. The thing on the tablet, in 2026, is unprecedented.

-- MAYA CALLOWAY, New York